TARGETING HIGH MOBILITY GROUP BOX PROTEIN 3 TO SENSITIZE CHEMORESISTANT HUMAN OVARIAN CANCER CELLS TO CISPLATIN IN VIVO

University Of Texas At Austin, Austin TX

Investigators